MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr | ₹-93 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-37 Cr |
| Mar2024 | ₹76 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹155 Cr |
| Mar2021 | ₹-93 Cr |
How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-37 Cr | Negative | |
| Mar2024 | ₹76 Cr | 290.95 | |
| Mar2023 | ₹19 Cr | -87.48 | |
| Mar2022 | ₹155 Cr | Positive | |
| Mar2021 | ₹-93 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,780.2 Cr | 7.7% | 0.9% | 2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,104.0 Cr | 3.5% | -1.5% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,119.0 Cr | 1.1% | -1.1% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,871.0 Cr | -0.2% | -0.3% | 35% | Stock Analytics | |
| CIPLA | ₹114,334.0 Cr | 3.1% | 1% | -11.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,761.0 Cr | 1.1% | -2.1% | -5.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 7.7% |
0.9% |
2.1% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses